This Phase 2 proposal will further the development of a fundamentally new, broadly applicable technology (Platypus technology) for the rapid, label-free detection of proteins. In Phase 1, we demonstrated the use of liquid crystals in combination with affinity contact printing for the detection of antibodies from multiple species and of multiple isotypes. In this proposal, we develop alternatives to microscopic and camera dependent methods for analysis of this technology and we transform the technology into a multi-well format, suitable for rapid, customized multiplexing and appropriate for semi-automated high throughput testing. We also demonstrate the generality of the approach for antibody detection and we com pare Platypus Antibody Assay with ELISA and SN detection of antibodies using sera from WNV infected horses and avians. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
5R44AI049687-04
Application #
7227835
Study Section
Special Emphasis Panel (ZRG1-IDM-B (12))
Program Officer
Repik, Patricia M
Project Start
2001-09-15
Project End
2009-04-30
Budget Start
2007-05-01
Budget End
2009-04-30
Support Year
4
Fiscal Year
2007
Total Cost
$807,791
Indirect Cost
Name
Platypus Technologies, LLC
Department
Type
DUNS #
118040364
City
Madison
State
WI
Country
United States
Zip Code
53711